FDA Inspection 1255578 — Stephanie D. Pointer, M.D.
The FDA completed an inspection of Stephanie D. Pointer, M.D. on Nov 15, 2024 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 15, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Nashville, TN (United States)
Additional details
Clinical Investigator (CI)